Cancer rehabilitation indicators for Europe

Paolo Baili, Josette Hoekstra-Weebers, Elke Van Hoof, Hans Helge Bartsch, Luzia Travado, Miklos Garami, Francesca Di Salvo, Andrea Micheli, Piret Veerus

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.

Original languageEnglish
Pages (from-to)1356-1364
Number of pages9
JournalEuropean Journal of Cancer
Volume49
Issue number6
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Rehabilitation
Neoplasms
Registries
Return to Work
Confidentiality
Population
Health Status
Survivors
Quality of Life
Databases
Surveys and Questionnaires

Keywords

  • Cancer rehabilitation
  • Cancer survivorship
  • EUROCHIP
  • Europe

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Baili, P., Hoekstra-Weebers, J., Van Hoof, E., Bartsch, H. H., Travado, L., Garami, M., ... Veerus, P. (2013). Cancer rehabilitation indicators for Europe. European Journal of Cancer, 49(6), 1356-1364. https://doi.org/10.1016/j.ejca.2012.10.028

Cancer rehabilitation indicators for Europe. / Baili, Paolo; Hoekstra-Weebers, Josette; Van Hoof, Elke; Bartsch, Hans Helge; Travado, Luzia; Garami, Miklos; Di Salvo, Francesca; Micheli, Andrea; Veerus, Piret.

In: European Journal of Cancer, Vol. 49, No. 6, 04.2013, p. 1356-1364.

Research output: Contribution to journalArticle

Baili, P, Hoekstra-Weebers, J, Van Hoof, E, Bartsch, HH, Travado, L, Garami, M, Di Salvo, F, Micheli, A & Veerus, P 2013, 'Cancer rehabilitation indicators for Europe', European Journal of Cancer, vol. 49, no. 6, pp. 1356-1364. https://doi.org/10.1016/j.ejca.2012.10.028
Baili P, Hoekstra-Weebers J, Van Hoof E, Bartsch HH, Travado L, Garami M et al. Cancer rehabilitation indicators for Europe. European Journal of Cancer. 2013 Apr;49(6):1356-1364. https://doi.org/10.1016/j.ejca.2012.10.028
Baili, Paolo ; Hoekstra-Weebers, Josette ; Van Hoof, Elke ; Bartsch, Hans Helge ; Travado, Luzia ; Garami, Miklos ; Di Salvo, Francesca ; Micheli, Andrea ; Veerus, Piret. / Cancer rehabilitation indicators for Europe. In: European Journal of Cancer. 2013 ; Vol. 49, No. 6. pp. 1356-1364.
@article{159d20ec42904135b28edeb44adc1767,
title = "Cancer rehabilitation indicators for Europe",
abstract = "Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.",
keywords = "Cancer rehabilitation, Cancer survivorship, EUROCHIP, Europe",
author = "Paolo Baili and Josette Hoekstra-Weebers and {Van Hoof}, Elke and Bartsch, {Hans Helge} and Luzia Travado and Miklos Garami and {Di Salvo}, Francesca and Andrea Micheli and Piret Veerus",
year = "2013",
month = "4",
doi = "10.1016/j.ejca.2012.10.028",
language = "English",
volume = "49",
pages = "1356--1364",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "6",

}

TY - JOUR

T1 - Cancer rehabilitation indicators for Europe

AU - Baili, Paolo

AU - Hoekstra-Weebers, Josette

AU - Van Hoof, Elke

AU - Bartsch, Hans Helge

AU - Travado, Luzia

AU - Garami, Miklos

AU - Di Salvo, Francesca

AU - Micheli, Andrea

AU - Veerus, Piret

PY - 2013/4

Y1 - 2013/4

N2 - Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.

AB - Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.

KW - Cancer rehabilitation

KW - Cancer survivorship

KW - EUROCHIP

KW - Europe

UR - http://www.scopus.com/inward/record.url?scp=84875694443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875694443&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2012.10.028

DO - 10.1016/j.ejca.2012.10.028

M3 - Article

C2 - 23237740

AN - SCOPUS:84875694443

VL - 49

SP - 1356

EP - 1364

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 6

ER -